C4 Therapeutics

CCCC

NASDAQHealth Care

Income Statement

Total Revenue$35.58M

Gross Profit$35.58M

Operating Income$-119.61M

EBITDA$-96.95M

EBIT$-105.19M

Pre-tax Income$-104.87M

Net Income$-105.32M

Cash Equivalent$72.92M

Total Debt$67.75M

Book Value$241M

Book Value Per Share3.48

Return on Equity (ROE)-48.76%

Return on Assets (ROA)-30.12%

Return on Invested Capital (ROI)-48.76%

Net Profit Margin-295.96%

Current Ratio5.71

Quick Ratio5.49

Long-Term Debt / Equity0.00